Kris Sachsenmeier
Company: Compass Therapeutics
Job title: VP Trans Sci
Seminars:
Panel Discussion: Supercharging Oncology Therapeutics with Unprecedented Patient Surveillance to Provide Insights On Risk of Relapse & Improve Survival 3:45 pm
Leveraging MRD to act as a biomarker for patient relapse Developing surrogate endpoints using ctDNA Investigating the potential of multi-markers in advancing patient monitoringRead more
day: Day One